FMP

FMP

Blog
Screener
Extras

IMTX - Immatics N.V.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treat

photo-url-https://financialmodelingprep.com/image-stock/IMTX.png

Immatics N.V.

IMTX

NASDAQ

12.94 USD

0.43 (3.32%)

About

ceo

Dr. Harpreet Singh Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.immatics.com

exchange

NASDAQ

Description

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I clinical trials, which include IMA201 that targets melanoma-associated antigen 4 or 8 in patients with solid tumors; IMA202 that targets melanoma-associated antigen 1 in patients with various solid tumors, including squamous non-small cell lung carci...

CIK

0001809196

ISIN

NL0015285941

CUSIP

N44445109

Address

Paul-Ehrlich-Strasse 15

Phone

49 7071 5397 0

Country

DE

Employee

433

IPO Date

Dec 12, 2018

Summary

CIK

0001809196

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

N44445109

ISIN

NL0015285941

Country

DE

Price

12.94

Beta

0.67

Volume Avg.

483.13k

Market Cap

1.33B

Shares

-

52-Week

5.9-13.155

DCF

-9.45

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-10.61

P/B

-

Website

https://www.immatics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest IMTX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep